WARWICK, New York — Jehovah’s Witnesses have announced a significant adjustment to their religious guidance on the medical use of blood, allowing individual members to decide for themselves whether to accept four primary blood components—red blood cells, white blood cells, plasma and platelets—while maintaining the faith’s longstanding position against transfusions of whole blood.
The Governing Body of Jehovah’s Witnesses announced the change on September 18, 2026, from the organization’s world headquarters in Warwick, New York. According to the official announcement, the use of these four components obtained from another person’s donated blood will now be considered a matter of individual conscience rather than a decision governed by a uniform religious prohibition.
“Each Christian must make his own personal decision about the use of these four primary components in all medical and surgical care,” Governing Body member Geoffrey W. Jackson said in explaining the adjustment.
The new guidance also gives individual Witnesses the responsibility of deciding whether they are willing to donate blood specifically for the production of components or fractions that may be used in another person’s medical treatment. The organization’s official medical information states that decisions involving the four primary components are now matters of personal conscience for each Witness patient.
The change, however, should not be interpreted as a removal of the religion’s opposition to whole-blood transfusions. Jehovah’s Witnesses continue to teach that receiving whole blood conflicts with their interpretation of the biblical instruction to “abstain from blood,” including the passage in Acts 15:20. The September announcement specifically states that the religious position against transfusion of whole blood remains unchanged.
The distinction is important for healthcare professionals caring for Jehovah’s Witness patients. Under the revised guidance, a patient may personally decide to accept red cells, white cells, plasma or platelets even though another member of the same faith may decline them. The organization says that this personal-decision principle, which had previously applied to certain blood-derived therapies and management of a patient’s own blood, has now been extended to the four primary components obtained from donor blood.
International spokesman Paul Gillies emphasized that the adjustment does not change the religious significance Jehovah’s Witnesses attach to blood. He said members are expected to consider the issue carefully through prayer, study and examination of biblical principles before making their own medical decisions. He also indicated that congregations are not expected to intervene in choices that fall within an individual member’s conscience.
The September decision follows another adjustment announced earlier in 2026 concerning a patient’s own blood. In March, Jehovah’s Witnesses said individual members could make personal decisions regarding certain medical procedures involving the collection, storage and subsequent use of their own blood. The latest announcement extends individual decision-making further by addressing the four major components obtained from another person’s blood.
The development could have practical implications in hospitals worldwide, particularly in surgery, emergency medicine, oncology and other areas where specific blood components may be medically indicated. It also places greater responsibility on healthcare professionals to discuss treatment options directly with individual Jehovah’s Witness patients rather than assuming that every patient will make the same decision about blood components.
For patients, physicians and nurses, the central point of the September 18 announcement is therefore clear: Jehovah’s Witnesses continue to reject whole-blood transfusions as a religious position, but acceptance of red blood cells, white blood cells, plasma and platelets is now left to the personal conscience of each individual Witness.
